Dr. Beman Khulpateea is a Fellowship-trained gynecologic oncologist, providing advanced surgical options for women facing the challenge of a GYN cancer diagnosis.
Mercy's team of cancer doctors diagnose and treat melanoma, a very serious form of skin cancer.
Radiation Oncology at Mercy, led by esteemed radiation oncologist Dr. Maria Jacobs, offers cancer patients access to state-of-the-art radiation therapies in Downtown Baltimore.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
A 2020 TOP DOC
Dr. Mary Harris is a regionally recognized gastroenterologist and Medical Co-Director of Mercy's Center for Inflammatory Bowel and Colorectal Diseases.
A 2020 TOP DOC
Experienced colon and rectal surgeon Dr. Jeffery Nelson serves as the Surgical Director of Mercy's Center for Inflammatory Bowel and Colorectal Diseases.
Dr. Matilda Hagan, a dedicated IBD specialist, serves as Medical Co-Director of The Center for Inflammatory Bowel and Colorectal Diseases at Mercy.
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
Smokers who quit have a 65 percent lower risk of a Crohn's disease flare-up and are less likely to need steroids or other medications.